Agilent Technologies, Inc. $A Shares Sold by Harvest Portfolios Group Inc.

Harvest Portfolios Group Inc. trimmed its stake in Agilent Technologies, Inc. (NYSE:A) by 17.2% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 407,816 shares of the medical research company’s stock after selling 84,809 shares during the quarter. Harvest Portfolios Group Inc. owned approximately 0.14% of Agilent Technologies worth $55,492,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of A. Board of the Pension Protection Fund acquired a new position in shares of Agilent Technologies in the 4th quarter worth $27,000. Navalign LLC acquired a new position in shares of Agilent Technologies in the 4th quarter worth $27,000. Physician Wealth Advisors Inc. grew its holdings in shares of Agilent Technologies by 490.0% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock worth $30,000 after acquiring an additional 196 shares during the last quarter. Entrust Financial LLC acquired a new position in shares of Agilent Technologies in the 4th quarter worth $31,000. Finally, Torren Management LLC acquired a new position in shares of Agilent Technologies in the 4th quarter worth $32,000.

Wall Street Analysts Forecast Growth

A has been the topic of a number of recent research reports. HSBC initiated coverage on Agilent Technologies in a report on Tuesday, January 20th. They issued a “buy” rating and a $180.00 target price on the stock. TD Cowen decreased their target price on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Wells Fargo & Company decreased their target price on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research report on Thursday, February 26th. UBS Group decreased their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Finally, Barclays decreased their target price on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $163.71.

Agilent Technologies Price Performance

A opened at $110.43 on Wednesday. The stock has a market cap of $31.21 billion, a price-to-earnings ratio of 24.38, a PEG ratio of 2.36 and a beta of 1.22. Agilent Technologies, Inc. has a 1 year low of $107.07 and a 1 year high of $160.27. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44. The stock has a fifty day moving average price of $114.85 and a 200 day moving average price of $130.10.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). The firm had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. Agilent Technologies’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same period in the previous year, the business posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Analysts forecast that Agilent Technologies, Inc. will post 5.95 EPS for the current fiscal year.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.